Document Detail

The Impact of Anemia on Long-Term Clinical Outcome in Patients Undergoing Revascularization With the Unrestricted Use of Drug-Eluting Stents.
MedLine Citation:
PMID:  22456025     Owner:  NLM     Status:  Publisher    
BACKGROUND: Anemia is frequent among patients with cardiovascular disease and adversely affects prognosis. The objective of this analysis was to assess the impact of anemia on long-term clinical outcomes among patients undergoing percutaneous coronary intervention (PCI) with the unrestricted use of drug-eluting stents (DES). METHODS AND RESULTS: Between April 2002 to March 2009, 6528 consecutive patients underwent PCI with the unrestricted use of DES. Among patients with anemia according to the criteria by the World Health Organization (WHO) (hemoglobin <130 g/L for men and <120 g/L for women, respectively) patients below the 25(th) percentile separately for men and women were defined to have severe anemia. We compared clinical outcomes among patients with severe anemia and no/mild anemia during long-term follow-up through 4 years. Whereas 21.6% of patients were found to have anemia according to the WHO definition, 347 patients (5.5%) had severe anemia (mean hemoglobin, 98±11 g/L). Severe anemia was more prevalent among the elderly (P<0.001), diabetics (P<0.001), and patients with chronic kidney disease (P<0.001). In adjusted analyses, severe anemia was associated with an increased risk of death (hazard ratio, 1.86; 95% confidence interval, 1.37-2.52; P<0.0001), cardiac death (hazard ratio, 2.32; 95% confidence interval, 1.57-3.43; P<0.0001), and myocardial infarction (hazard ratio, 2.02; 95% confidence interval, 1.36-3.01; P=0.00054) as compared with no/mild anemia without significant interaction across sexes (P=0.86) and acute coronary syndromes (P=0.61) and a trend toward a particularly high risk of mortality among anemic patients <65 years of age (P=0.07). Severe anemia resulted in a greater risk of overall definite stent thrombosis (hazard ratio, 2.59; 95% confidence interval, 1.48-4.54; P=0.00089). CONCLUSIONS: Severe anemia is common among patients undergoing PCI with the unrestricted use of DES and adversely affects long-term prognosis, including survival.
Thomas Pilgrim; Florian Vetterli; Bindu Kalesan; Giulio G Stefanini; Lorenz Räber; Stefan Stortecky; Steffen Gloekler; Ronald K Binder; Peter Wenaweser; Aris Moschovitis; Ahmed A Khattab; Lutz Buellesfeld; Marcel Zwahlen; Bernhard Meier; Peter Jüni; Stephan Windecker
Related Documents :
22697085 - Effects of oral hyposensitization therapy with nickel on haemoglobin and haematocrit va...
2295405 - Cessation of cryptosporidium-associated diarrhea in an acquired immunodeficiency syndro...
15054525 - Gastrocolic fistula secondary to nonsteroidal anti-inflammatory drugs abuse in a cirrho...
3113795 - Peptic ulcer--current status.
24366775 - Solitary congenital hypertrophy of the retinal pigment epithelium features by high-defi...
17899425 - Pyrexia of unknown origin (puo) in a hemodialysis patient.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-27
Journal Detail:
Title:  Circulation. Cardiovascular interventions     Volume:  -     ISSN:  1941-7632     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101499602     Medline TA:  Circ Cardiovasc Interv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Oscillococcinum for influenza treatment.
Next Document:  Impact of frequency-domain optical coherence tomography guidance for optimal coronary stent implanta...